Rivastigmine in the Treatment of Postoperative Delirium: a Pilot Clinical Trial

Completed · Phase 4 · Has a placebo group

Conditions studied: Delirium, Postoperative Cognitive Dysfunction

In brief

The purpose of this study is to determine whether preoperative administration of Rivastigmine prevents the incidence of postoperative delirium in patients undergoing major surgery as well as postoperative cognitive dysfunction.

Key facts

Study ID

NCT00835159

Run by

NYU Langone Health

People needed

30

Starts

2008-12-01

Expected to finish

2010-10-01

Last updated by the study team

2015-02-09

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 65 ≥ y.o. undergoing major elective surgery over 2 hours in length with one or more of the following:
• Preoperative cognitive impairment
• Age > 70 y.o.
• Use of psychoactive medications
• History of prior delirium
• Severe illness/co-morbidity

You may not qualify if…

• Delirium on admission Profound dementia No spoken/written English An emergent procedure Hypersensitivity to Rivastigmine

Where it is running

• NYU Langone Medical Center, Department of Anesthesiology 550 First Avenue, RR-603 — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.